/Compositions And Methods For Treatment Of Netherton Syndrome With Lekti Expressing Recombinant Microbes
Abstract
The present disclosure provides, inter alia, engineered microbes expressing recombinant LEKTI domains that are effective to treat or ameliorate the symptoms of Netherton Syndrome. In certain embodiments, compositions, methods, and kits are provided comprising LEKTI domain expressing microbes.
Full Text
What is claimed is:
The present disclosure provides, inter alia, engineered microbes expressing recombinant LEKTI domains that are effective to treat or ameliorate the symptoms of Netherton Syndrome. In certain embodiments, compositions, methods, and kits are provided comprising LEKTI domain expressing microbes.
Timeline
Filed
03/18/2026Published
07/09/2026Granted
Not AvailableIPC Codes(5)
C07K 14/81:Protease inhibitors
A61K 9/00:Medicinal preparations characterised by special physical form
A61K 35/74:Bacteria (therapeutic use of a bacterial protein A61K 38/00)